DA Davidson analyst Manuel Navas maintains 1st Source (NASDAQ:SRCE) with a Neutral and lowers the price target from $53 to $51.
Where Myriad Genetics Stands With Analysts
Within the last quarter, Myriad Genetics (NASDAQ:MYGN) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…